James Andrea S.
- SEC CIK
- 0002027010
No open-market purchases or sales filed in the past year.
Current role at each company
- IMDX Insight Molecular Diagnostics Inc.Chief Financial Officeras of Mar 30, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists James Andrea S. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2025 (view filing) | Feb 7 | 4 days | James Andrea S.Chief Financial Officer | PPurchaseCommon Stock, no par value | +97.6K | $2.05 | +$200.0K | +181.8%151.2K after | |
| Dec 9, 2024 (view filing) | Dec 5 | 4 days | James Andrea S.Chief Financial Officer | PPurchaseCommon Stock, no par value | +20.0K | $2.29 | +$45.8K | +59.4%53.7K after | |
| Oct 4, 2024 (view filing) | Oct 2 | 2 days | James Andrea S.Chief Financial Officer | PPurchaseCommon Stock, no par value | +33.7K | $2.97 | +$100.0K | New position33.7K after |